Does TICAGRELOR Cause Stent placement? 94 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Stent placement have been filed in association with TICAGRELOR (Ticagrelor). This represents 0.4% of all adverse event reports for TICAGRELOR.
94
Reports of Stent placement with TICAGRELOR
0.4%
of all TICAGRELOR reports
1
Deaths
59
Hospitalizations
How Dangerous Is Stent placement From TICAGRELOR?
Of the 94 reports, 1 (1.1%) resulted in death, 59 (62.8%) required hospitalization, and 1 (1.1%) were considered life-threatening.
Is Stent placement Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TICAGRELOR. However, 94 reports have been filed with the FAERS database.
What Other Side Effects Does TICAGRELOR Cause?
Dyspnoea (3,156)
Myocardial infarction (1,749)
Death (1,510)
Off label use (1,084)
Fatigue (1,081)
Chest pain (1,075)
Contusion (970)
Dizziness (811)
Vascular stent thrombosis (700)
Haemorrhage (676)
What Other Drugs Cause Stent placement?
RANOLAZINE (593)
EVOLOCUMAB (244)
ADALIMUMAB (227)
ROSIGLITAZONE (196)
ETANERCEPT (174)
CLOPIDOGREL BISULFATE (167)
RIVAROXABAN (122)
ASPIRIN (118)
APIXABAN (116)
MACITENTAN (108)
Which TICAGRELOR Alternatives Have Lower Stent placement Risk?
TICAGRELOR vs TICLOPIDINE
TICAGRELOR vs TIGECYCLINE
TICAGRELOR vs TIKOSYN
TICAGRELOR vs TILDRAKIZUMAB
TICAGRELOR vs TILDRAKIZUMAB-ASMN